Long-term safety and efficacy profile of simvastatin

Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?

1989 • 2,473 citations

Epidemiologic Study of Sleep Disturbances and Psychiatric Disorders

1989 • 2,103 citations

Efficacy and long-term adverse effect pattern of lovastatin

1988 • 338 citations

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.

1987 • 196 citations

EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA

1986 • 157 citations

Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme a reductase inhibitors

1989 • 136 citations

Simvastatin: The clinical profile

1989 • 80 citations

Clinical experience with lovastatin

1990 • 79 citations

Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia

1988 • 79 citations

Estimating incidence from age‐specific prevalence for irreversible diseases with differential mortality

1986 • 75 citations

Effects of Simvastatin and Cholestyramine in Familial and Nonfamilial Hypercholesterolemia

1990 • 64 citations

Effects of simvastatin and probucol in hypercholesterolemia (simvastatin multicenter study group II)

1989 • 50 citations

Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia

1988 • 50 citations

Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol

1989 • 48 citations

HMG CoA Reductase Inhibitors

1988 • 30 citations

Simvastatin: A New HMG CoA Reductase Inhibitor

1990 • 8 citations